Recent Updates
Recently added Catalysts

Venlafaxine

Phase 1

Healthy | Small molecule | Other |Dr. Reddy's Laboratories Ltd|Last Updated: Jan 19, 2012

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLEDDMC
Total Trials1
Total Enrollment33

FDA Designations

No designations recorded

Clinical trial landscape

Venlafaxine · 1 trial · 1 indication

Phase 1 1
NCT01512459Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed ConditionsHealthy
COMPLETED33 Analytics
PHASE1COMPLETED
Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions
Healthy
NCT0151245933
Unlock trial analytics

Study Endpoints

Primary Endpoints

Area Under Curve (AUC)
predose, 1.00, 3.00, 4.00, 5.00, 6.00, 7.00, 8.00, 9.00, 10.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours post-dose
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Venlafaxine MR Capsules 150EXPERIMENTALVenlafaxine MR Capsules 150 of Dr.Reddy's Laboratories Limited
Effexor XR 150 mg CapsulesACTIVE_COMPARATOREffexor XR 150 mg Capsules of Wyeth Laboratories Philadelphia, PA, USA

Interventions

NameTypeDescription
VenlafaxineDRUGVenlafaxine MR Capsules 150 mg
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 45 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: Subjects must fulfill all of the following criteria to be considered for inclusion into this study: * Subjects who will provide written informed consent. * Subjects must be healthy human beings within 18-45 years of age (inclusive) weighing at least 50 kg. * Having a Body mass ...

Countries:India
Unlock Eligibility Criteria